Kenvue (KVUE) Q3 earnings results surpassed expectations, sending its share value up by 3.07% on November 7, 2024. Despite missing revenue targets due to weak skin health and beauty sales, the company's positive earnings guidance for FY 2024 and the quarterly cash dividend of $0.205 maintained investors' confidence. The firm's expanded production and trusted product brands are recognized to drive growth, even as it faces pressure from activist investor,
Starboard, who acquired a noticeable stake and seeks changes. The acquisition has spurred speculations that Starboard may help boost the value in Kenvue's skin and beauty business. Concurrent Investment Advisors and M&G Plc are among firms growing their position in Kenvue while Easterly Investment Partners, Robeco Institutional Asset Management, and Crestwood Advisors Group reduced their stakes. With
updated FY 2024 earnings guidance and a new 12-month high, KVUE proves to be a contender for Goldman Sachs Fund Manager's top pick. Despite some negative oversight regarding the company's soft earnings, KVUE's strong financials seem to be guiding the market.
Kenvue KVUE News Analytics from Mon, 13 May 2024 07:00:00 GMT to Sat, 09 Nov 2024 20:48:26 GMT -
